China`s BeiGene gets FDA approval for drug to treat rare form of lymphoma
(Reuters Health)

The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd`s lymphoma treatment, validating the China-based drugmaker`s strategy of largely using data from trials held outside the United States to file for approval.